Search

Displaying results 3241 - 3250 of 10000 in total
  1. Indication

    Clostridium Difficile Associated Diarrhea (CDAD)

    go.drugbank.com/conditions/DBCOND0085319
    Drugs: Fidaxomicin · Vancomycin
    Synonyms: Enterocolitis due to Clostridium difficile
  2. Indication

    Metrorrhagia

    go.drugbank.com/conditions/DBCOND0001309
    Drugs: Lynestrenol
    Synonyms: Bleeding unrelated to menstrual cycle
  3. Indication

    Perennial Allergic Rhinitis (PAR)

    go.drugbank.com/conditions/DBCOND0058482
    Drugs: Azelastine · Beclomethasone dipropionate · Cetirizine · Ciclesonide · Cortisone acetate · Cromoglicic acid +12 more
    Synonyms: Allergic rhinitis due to allergen
  4. Indication

    Vascular Dementia (VaD)

    go.drugbank.com/conditions/DBCOND0132452
    Drugs: Donepezil
    Synonyms: Vascular dementia as a result of infarction of the brain due to vascular disease, including hypertensive cerebrovascular disease.
  5. Drug

    Eftrenonacog alfa

    go.drugbank.com/drugs/DB11608
    Approved

    It is an X-linked genetic disease caused by mutation of the gene for coagulation protein factor IX (FIX), leading to decreased levels of endogenous factor IX and increased susceptibility to recurrent bleeding … Eftrenonacog alfa acts as a replacement therapy to restore the levels of factor IX and allow normal hemostasis.

    Products: ALPROLIX® 250 UI
  6. Drug

    Chlorothiazide

    go.drugbank.com/drugs/DB00880
    ApprovedInvestigationalVet approved

    A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)

    Mixtures: Supres 150 Tab, Supres 250 Tab
  7. Drug

    Isoeugenol

    go.drugbank.com/drugs/DB14188
    Approved

    It is also a significant dermatologic sensitizer and allergen, and as a result has been restricted to 200 p.p.m. since 1998 according to guidelines issued by the fragrance industry [A34278]. … Allergic reactivity to Isoeugenol may be identified with a patch test.

  8. Drug

    Margetuximab

    go.drugbank.com/drugs/DB14967
    ApprovedInvestigational

    [A225751, A225756, A225766, A191829, L27986] Margextuximab was granted FDA approval on December 16, 2020, and is currently marketed under the trademark MARGENZA™ by MacroGenics, Inc.[L27986] … Of the various subtypes of breast cancer, HER2-positive breast cancer is characterized by _ERBB2_ overexpression, a higher grade, a more aggressive phenotype, and a worse prognosis compared to HER2-negative

  9. Drug

    Avibactam

    go.drugbank.com/drugs/DB09060
    ApprovedInvestigational

    infections, including pyelonephritis caused by antibiotic resistant-pathogens, including those caused by multi-drug resistant gram-negative bacterial pathogens. … This combination was approved by the FDA on February 25, 2015 for the treatment of complicated intra-abdominal infections in combination with metronidazole, and the treatment of complicated urinary tract

    Mixtures: ZAVİCEFTA 2 G/0.5 G İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 10 ADETProducts: ZAVICEFTA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 2G/0.5G
  10. Drug

    Gantenerumab

    go.drugbank.com/drugs/DB12034
    Investigational

    to reduce Aβ aggregation and remove Aβ plaques. … Gantenerumab binds to a unique Aβ epitope compared to other anti-Aβ antibodies and preferentially recognizes Aβ oligomers and fibrils over monomers.[A244720]